← Leaderboards
David W. Clapp
Indiana University Indianapolis
$30,065,006
Attributed
$35,258,230
Total exposure
29
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$61,460,452 · 32
By mechanism
U54$25,974,479 · 7
R01$14,224,530 · 8
U01$5,874,201 · 3
P01$4,106,985 · 2
T32$3,698,460 · 3
K12$2,883,225 · 2
Top collaborators
- Kevin M Shannon10 shared
- Hal E. Broxmeyer7 shared
- Grover Carlton Bagby5 shared
- Helmut Hanenberg5 shared
- Feng-Chun Yang5 shared
- Steven P Angus3 shared
- Mark R. Kelley3 shared
- Carmella Evans Molina3 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Helmut Hanenberg$522,997
- Steven David Rhodes$737,024
- Emily Elizabeth White$41,905
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorCellsResearch PersonnelPlexiform NeurofibromaResponseMutationClinical TrialsNeurofibromatosis 1InsightSignal TransductionGeneticComplexAffectFundingProgramsMorbidity - Disease RateMolecularTumor Suppressor GenesGenetically Engineered MouseChildIn VivoMalignant - DescriptorNf1 Gene
Grant awards (145)
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,300,532
U54 · FY2025 · CA · contact PI
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors$415,205
R01 · FY2025 · NS · contact PI
Identification of novel therapeutic combinations for NF2 schwannomas$403,851
R01 · FY2025 · NS · contact PI
Indiana Pediatric Scientist Award (IPSA)$324,000
K12 · FY2025 · HD · contact PI
Preclinical-clinical trials collaboration to effectively advance new combination therapies for atypical neurofibroma in neurofibromatosis type 1$316,195
U01 · FY2025 · CA · contact PI
Administrative Core$287,567
U54 · FY2025 · CA · contact PI
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic$287,567
U54 · FY2025 · CA · contact PI
The Medical Physician Engineers, Scientists, and Clinicians Preparatory Program [MPESC-Prep]$160,320
R25 · FY2025 · HL · contact PI
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)$141,457
T32 · FY2025 · CA
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,208,392
U54 · FY2024 · CA · contact PI
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic$562,447
U54 · FY2024 · CA · contact PI
Identification of novel therapeutic combinations for NF2 schwannomas$435,260
R01 · FY2024 · NS · contact PI
Indiana Pediatric Scientist Award (IPSA)$324,000
K12 · FY2024 · HD · contact PI
Preclinical-clinical trials collaboration to effectively advance new combination therapies for atypical neurofibroma in neurofibromatosis type 1$308,685
U01 · FY2024 · CA · contact PI
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors$247,369
R01 · FY2024 · NS · contact PI
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)$164,494
T32 · FY2024 · CA
The Medical Physician Engineers, Scientists, and Clinicians Preparatory Program [MPESC-Prep]$160,320
R25 · FY2024 · HL · contact PI
Administrative Core$83,453
U54 · FY2024 · CA · contact PI
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors$72,713
R01 · FY2024 · NS · contact PI
FRONTIERS IN SCIENCE CONFERENCE$10,000
R13 · FY2024 · HD · contact PI
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,139,494
U54 · FY2023 · CA · contact PI
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic$543,627
U54 · FY2023 · CA · contact PI
Preclinical-clinical trials collaboration to effectively advance new combination therapies for atypical neurofibroma in neurofibromatosis type 1$495,641
U01 · FY2023 · CA · contact PI
Identification of novel therapeutic combinations for NF2 schwannomas$463,348
R01 · FY2023 · NS · contact PI
Indiana Pediatric Scientist Award (IPSA)$324,000
K12 · FY2023 · HD · contact PI
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors$263,856
R01 · FY2023 · NS · contact PI
The Medical Physician Engineers, Scientists, and Clinicians Preparatory Program [MPESC-Prep]$160,320
R25 · FY2023 · HL · contact PI
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)$158,847
T32 · FY2023 · CA
Administrative Core$80,436
U54 · FY2023 · CA · contact PI
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors$72,713
R01 · FY2023 · NS · contact PI
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors$44,177
R01 · FY2023 · NS · contact PI
FRONTIERS IN SCIENCE CONFERENCE$10,000
R13 · FY2023 · HD · contact PI
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,139,494
U54 · FY2022 · CA · contact PI
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic$540,926
U54 · FY2022 · CA · contact PI
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors$415,205
R01 · FY2022 · NS · contact PI
F-box ubiquitin ligases destabilize neurofibromin$344,531
R01 · FY2022 · NS · contact PI
The Medical Physician Engineers, Scientists, and Clinicians Preparatory Program [MPESC-Prep]$160,320
R25 · FY2022 · HL · contact PI
Administrative Core$82,701
U54 · FY2022 · CA · contact PI
FRONTIERS IN SCIENCE CONFERENCE$10,000
R13 · FY2022 · HD · contact PI
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,198,683
U54 · FY2021 · CA · contact PI
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic$570,750
U54 · FY2021 · CA · contact PI
F-box ubiquitin ligases destabilize neurofibromin$344,531
R01 · FY2021 · NS · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$87,201
T32 · FY2021 · HL · contact PI
Administrative Core$86,187
U54 · FY2021 · CA · contact PI
FRONTIERS IN SCIENCE CONFERENCE$10,000
R13 · FY2021 · HD · contact PI
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis$548,019
R01 · FY2020 · HL · contact PI
F-box ubiquitin ligases destabilize neurofibromin$344,531
R01 · FY2020 · NS · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$331,293
T32 · FY2020 · HL
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis$46,610
R01 · FY2020 · HL · contact PI
FRONTIERS IN SCIENCE CONFERENCE$10,000
R13 · FY2020 · HD · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,124,182
U54 · FY2019 · CA · contact PI
Indiana Medical Scientist/Engineer Training Program$523,673
T32 · FY2019 · GM · contact PI
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis$393,750
R01 · FY2019 · HL · contact PI
F-box ubiquitin ligases destabilize neurofibromin$344,531
R01 · FY2019 · NS · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$193,350
T32 · FY2019 · HL
Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials$114,840
U54 · FY2019 · CA · contact PI
Core C: Administrative Core$44,404
U54 · FY2019 · CA · contact PI
FRONTIERS IN SCIENCE CONFERENCE$6,000
R13 · FY2019 · HD · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,102,055
U54 · FY2018 · CA · contact PI
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis$393,750
R01 · FY2018 · HL · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$380,561
T32 · FY2018 · HL
F-box ubiquitin ligases destabilize neurofibromin$344,531
R01 · FY2018 · NS · contact PI
Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials$123,492
U54 · FY2018 · CA · contact PI
Core C: Administrative Core$47,766
U54 · FY2018 · CA · contact PI
FRONTIERS IN SCIENCE CONFERENCE$6,000
R13 · FY2018 · HD · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,271,783
U54 · FY2017 · CA · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$430,810
T32 · FY2017 · HL
Indiana Pediatric Scientist Award(IPSA)$387,638
K12 · FY2017 · HD · contact PI
Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials$135,478
U54 · FY2017 · CA · contact PI
Core C: Administrative Core$46,376
U54 · FY2017 · CA · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$3,498
T32 · FY2017 · HL
Developmental and HyperActive Ras Tumor SPORE$2,162,000
U54 · FY2016 · CA · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$523,280
T32 · FY2016 · HL
Indiana Pediatric Scientist Award(IPSA)$331,680
K12 · FY2016 · HD · contact PI
Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials$121,754
U54 · FY2016 · CA · contact PI
Core C: Administrative Core$31,924
U54 · FY2016 · CA · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,384,507
U54 · FY2015 · CA · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$494,630
T32 · FY2015 · HL
Indiana Pediatric Scientist Award(IPSA)$328,547
K12 · FY2015 · HD · contact PI
Genetic Therapy for Fanconi Anemia$319,550
R01 · FY2015 · CA · contact PI
Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials$123,820
U54 · FY2015 · CA · contact PI
Core C: Administrative Core$27,842
U54 · FY2015 · CA · contact PI
Indiana Pediatric Scientist Award(IPSA)$431,680
K12 · FY2014 · HD · contact PI
Role of hematopoietic microenvironment in plexiform neurofibroma progression$375,274
P50 · FY2014 · NS · contact PI
Genetic Therapy for Fanconi Anemia$309,964
R01 · FY2014 · CA · contact PI
Indiana Pediatric Scientist Award(IPSA)$431,680
K12 · FY2013 · HD · contact PI
Role of hematopoietic microenvironment in plexiform neurofibroma progression$358,270
P50 · FY2013 · NS · contact PI
Genetic Therapy for Fanconi Anemia$300,377
R01 · FY2013 · CA · contact PI
Fanconi Anemia stem cells allow molecular characterization of acute leukemia$379,440
R01 · FY2012 · CA · contact PI
Role of hematopoietic microenvironment in plexiform neurofibroma progression$363,662
P50 · FY2012 · NS · contact PI
Genetic Therapy for Fanconi Anemia$319,550
R01 · FY2012 · CA · contact PI
Neurofibromatosis type 1 Gene Regulates Myelopoiesis$312,768
R01 · FY2012 · CA · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$438,900
U01 · FY2011 · NS · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$438,900
U01 · FY2011 · NS · contact PI
Fanconi Anemia stem cells allow molecular characterization of acute leukemia$380,935
R01 · FY2011 · CA · contact PI
Role of hematopoietic microenvironment in plexiform neurofibroma progression$331,696
P50 · FY2011 · NS · contact PI
Genetic Therapy for Fanconi Anemia$319,550
R01 · FY2011 · CA · contact PI
Neurofibromatosis type 1 Gene Regulates Myelopoiesis$314,738
R01 · FY2011 · CA · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$621,744
U01 · FY2010 · NS · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$621,744
U01 · FY2010 · NS · contact PI
Fanconi Anemia stem cells allow molecular characterization of acute leukemia$394,298
R01 · FY2010 · CA · contact PI
Role of hematopoietic microenvironment in plexiform neurofibroma progression$326,453
P50 · FY2010 · NS · contact PI
Neurofibromatosis type 1 Gene Regulates Myelopoiesis$324,865
R01 · FY2010 · CA · contact PI
Lentiviral Vectors for the Treatment of Fanconi Anemia$223,172
R41 · FY2010 · HL · contact PI
Gene Replacement Therapy in Hematopoietic Stem Cells$1,794,260
P01 · FY2009 · HL · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$696,319
U01 · FY2009 · NS · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$619,319
U01 · FY2009 · NS · contact PI
Evaluation of Genetic Therapy in Fancc and Fanca Mice$438,682
P01 · FY2009 · HL · contact PI
Fanconi Anemia stem cells allow molecular characterization of acute leukemia$393,269
R01 · FY2009 · CA · contact PI
Neurofibromatosis type 1 Gene Regulates Myelopoiesis$325,689
R01 · FY2009 · CA · contact PI
NF Center: From Animal Models to Therapeutics$218,133
P50 · FY2009 · NS · contact PI
Indiana Medical Scientist/Engineer Training Program$177,204
T32 · FY2009 · GM · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$77,000
U01 · FY2009 · NS · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$619,877
U01 · FY2008 · NS · contact PI
Preclinical Testing of Targeted Therapies for Neurofibromas$619,877
U01 · FY2008 · NS · contact PI
Evaluation of Genetic Therapy in Fancc and Fanca Mice$417,372
P01 · FY2008 · HL · contact PI
Fanconi Anemia stem cells allow molecular characterization of acute leukemia$397,686
R01 · FY2008 · CA · contact PI
Neurofibromatosis type 1 Gene Regulates Myelopoiesis$338,107
R01 · FY2008 · CA · contact PI
NF Center: From Animal Models to Therapeutics$212,903
P50 · FY2008 · NS · contact PI
Indiana Medical Scientist/Engineer Training Program$88,162
T32 · FY2008 · GM · contact PI
Evaluation of Genetic Therapy in Fancc and Fanca Mice$399,793
P01 · FY2007 · HL · contact PI
NF Center: From Animal Models to Therapeutics$217,573
P50 · FY2007 · NS · contact PI
Evaluation of Genetic Therapy in Fancc and Fanca Mice$379,988
P01 · FY2006 · HL · contact PI
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis$310,959
R01 · FY2006 · CA · contact PI
NF Center: From Animal Models to Therapeutics$202,847
P50 · FY2006 · NS · contact PI
Evaluation of Genetic Therapy in Fancc and Fanca Mice$377,796
P01 · FY2005 · HL
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis$333,781
R01 · FY2005 · CA
NF Center: From Animal Models to Therapeutics$208,895
P50 · FY2005 · NS
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis$498,147
R01 · FY2004 · CA
EVALUATION OF GENETIC THERAPY IN FANC MICE$299,094
P01 · FY2004 · HL
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis$484,270
R01 · FY2003 · CA
HEMATOPOIESIS AND LEUKEMIC TRANSFORMATION IN FAC MICE$324,407
R01 · FY2003 · HL
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis$331,525
R01 · FY2002 · CA
HEMATOPOIESIS AND LEUKEMIC TRANSFORMATION IN FAC MICE$324,144
R01 · FY2002 · HL
CORE--MOUSE$228,564
P30 · FY2002 · DK
EVALUATION OF GENETIC THERAPY IN FANC MICE$0
P01 · FY2002 · HL
HEMATOPOIESIS AND LEUKEMIC TRANSFORMATION IN FAC MICE$325,755
R01 · FY2001 · HL
CORE--MOUSE$228,564
P30 · FY2001 · DK
CORE--MOUSE$228,564
P30 · FY2001 · DK
NEUROFIBROMATOSIS TYPE 1 GENE REGULATES MYELOPOIESIS$44,888
R29 · FY2001 · CA
EVALUATION OF GENETIC THERAPY IN FANC MICE$0
P01 · FY2001 · HL
HEMATOPOIESIS AND LEUKEMIC TRANSFORMATION IN FAC MICE$222,275
R01 · FY2000 · HL
CORE--MOUSE$120,834
P30 · FY2000 · DK
NEUROFIBROMATOSIS TYPE 1 GENE REGULATES MYELOPOIESIS$105,000
R29 · FY2000 · CA
EVALUATION OF GENETIC THERAPY IN FANC MICE$0
P01 · FY2000 · HL